Irhythm acquires vitalconnect 2375m all cash deal

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 05 Oct, 16:48 UTC

iRhythm provides end-to-end cardiac monitoring services while VitalConnect’s monitoring platform supports multiple modalities.

businessscience

Sources

• T2Irhythm acquires vitalconnect 2375m all cash dealFierce Biotech / Fierce Healthcare / MedCity / GEN05 Oct, 16:48